首页> 外文期刊>European journal of medical research. >Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy
【24h】

Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy

机译:玻璃体内贝贝磺酸盐在中央性浆液性脉络膜视网膜病变中的近期疗效

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Purpose: To report the anatomic and functional outcome of intravitreal dobesilate to treat recurrent central serous chorioretinopathy (CSC).Methods: This is an interventional case report in which dobesilate was intravitreally injected in a case of recurrent CSC. Main measures included fundoscopy, Snellen visual acuity (VA) testing, fluorescein angiography and optical coherence tomography (OCT).Results: We present anatomical and functional evidences, obtained as early as eleven days after the treatment, of the efficacy of intravitreal dobesilate, in the treatment of chronic CSC condition. The effect after intravitreal dobesilate injection for CSC might be related to the normalization of retinal architecture.Conclusions: Intravitreal dobesilate may be an effective treatment option for recurrent CSC. ^g>Central serous chorioretinopathy, Fibroblast growth factor, Dobesilate, Intravitreal injection
机译:目的:报道玻璃体内贝贝硅酸盐治疗复发性中心性浆液性脉络膜视网膜病变(CSC)的解剖学和功能结局。方法:这是一例介入性病例报告,其中在复发性CSC病例中玻璃体内注射贝贝硅酸盐。主要措施包括眼底镜检查,Snellen视力(VA)测试,荧光素血管造影和光学相干断层扫描(OCT)。结果:我们提供了最早在治疗后11天获得的玻璃状贝贝酸盐玻璃体内疗效的解剖学和功能证据。慢性CSC病的治疗。玻璃体腔内注射贝贝酸盐治疗CSC可能与视网膜结构正常化有关。结论:玻璃体腔内注射贝贝酸盐可能是复发性CSC的有效治疗方法。 ^ g>中央浆液性脉络膜视网膜病变,成纤维细胞生长因子,Do贝硅酸盐,玻璃体内注射

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号